← All organizations

Highest phase reached
Phase 2
First clinical trial
Dec 1, 2015Last known activity
Dec 1, 2015
Timeline
1950s
- Sep 11, 1953
mercaptopurine— NDA Organization
- Sep 11, 1953
mercaptopurine— NDA Secondary Org
1990s
- Jun 1, 1994
Stason Pharmaceuticals, Inc.— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Approved for
Studied for
Marketed drugs (1)
Recent trials (1)
- NCT02693093Lead sponsorPhase 1/Phase 2Dec 1, 2015
Details
- Founded
- Irvine, CA, US Jun 1, 1994
- Last known activity
- Dec 1, 2015
Designations held
- Priority review